During C0VID-19, industry growth has slow-down, delay in approvals, and self-sufficiency in pharm-production supply chain and trend changes in consumption of health-market products along with ethical crisis could be anticipated as long-term impacts of COVID-19 pandemic on the pharmaceutical sector in both global and local levels.